Full Results From Moderna's Coronavirus Vaccine Study Will Take 2 Years, at Least

Moderna (NASDAQ:MRNA) plans to start a phase 3 clinical trial testing its mRNA-1273 coronavirus vaccine candidate in less than two weeks. But don't expect a quick turnaround of full study results. Moderna plans to follow patients for 759 days.

That's over two years.